Project Grant CLSS00000066560

The federal Project Grant award with ID DP2DA062283 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,542,500 grant, awarded on September 1, 2024, will support the development of novel econometric methods and a unified framework for integrating real-world evidence (RWE) to analyze inconclusive randomized controlled trials (RCTs) focused on opioid use disorder (OUD) treatments. The project, to be conducted by Weill...

The National Institute on Drug Abuse (NIDA) awarded a $220,668 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Amalgent Therapeutics, Inc. in Greenville, NC. This grant supports the development of a novel opioid adjuvant technology that aims to enhance the pain-relieving efficacy of opioid medications while mitigating risks such as abuse potential, tolerance, and neuropathic pain. The project has two key objectives: 1) investigating the mechanism by which the...

Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $453,062 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, with completion targeted for May 31, 2030. The research project, titled "Control of Opioid Receptor Signaling and Pharmacological Tolerance Through Endosomal Recycling and Retromer," will develop foundational knowledge regarding...

The Department of Justice, Office of Justice Programs, Bureau of Justice Assistance awarded a $1,600,000 Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838) Project Grant to the Southern Nevada Health District (SNHD) and sub-recipients Las Vegas Metropolitan Police Department (LVMPD) and University of Nevada, Las Vegas (UNLV). The grant will fund a collaborative initiative to address the opioid crisis in Clark County, Nevada through a public health-focused overdose...

This federal Project Grant award of $459,045, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is for a study titled "The Cascade of Care for Patients with Opioid Use Disorder Identified Through a Large Public Health System." The study aims to modify the existing Opioid Use Disorder (OUD) Cascade of Care model to better reflect the changing landscape of real-world OUD treatment, enabling critical research...

This $424,545 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a national survey on naloxone use and access. The survey, conducted by the RAND Corporation, will provide critical, timely evidence on the state of naloxone carrying and purchasing behavior in the U.S., including the impact of recently approved over-the-counter naloxone products. The project will monitor knowledge, barriers, and willingness-to-pay...

Federal Project Grant Summary Louisiana State University Health Sciences Center New Orleans received a $225,065 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on August 15, 2025, with a project completion date of July 31, 2027. The award supports early-stage discovery research investigating the renin system as a novel therapeutic target for treating chronic pain and opioid use disorder (OUD). Specifically, the...

The City of Longview was awarded a $953,468 Project Grant from the U.S. Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838). The grant will fund an opioid use intervention strategy and public education campaign in the Longview, Texas area. Key components include: Implementing an alternative 911 response model by adding a Community Health Paramedic to provide immediate medical assistance, screenings,...

The U.S. Department of Justice's Bureau of Justice Assistance (BJA) awarded a $1,600,000 Project Grant under the Comprehensive Opioid, Stimulant, and Substance Use Program (CFDA 16.838) to Pierce County, WA. The grant will fund the Mobile Opioid Outreach and Treatment Project, which will deliver evidence-based opioid use disorder (OUD) treatment, including medication-assisted treatment (MAT), harm reduction activities, wound/basic health care, and telehealth services, via a fully equipped mobile...

Federal Grant Award Summary Altrumed LLC received a $808,156 Project Grant award dated August 15, 2025, from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate device-agnostic software for opioid overdose detection and intervention. The grant supports a one-year Phase I project focused on creating DOVE (Device-agnostic Overdose Detection and Verification Engine), a shoulder-wearable sensor system integrated with...